We present a novel method for extracting cancer signatures by applying statistical risk models (http://ssrn.com/abstract=2732453) from quantitative finance to cancer genome data. Using 1389 whole genome sequenced samples from 14 cancers, we identify an "overall" mode of somatic mutational noise. We give a prescription …
On-device research index
arXiv research
A locally-built, LLM-digested index of recent arXiv papers in quant finance, geometry/topology, and statistical ML — keyword search served straight from SQLite on this machine.
169,291 papers · 148 categories
Trend · papers per month
48 results for “cancer signatures”
New *K-means method finds cancer signatures without NMF.
problem Identifying cancer signatures from genome data.
method Applying *K-means clustering to 1,389 cancer samples.
result 3 cancers lack cluster-like structures, 2 have high correlations.
New method uses probabilistic independence to discover disease signatures from medical records.
problem Insufficiently precise diagnosis of clinical disease leading to treatment failures.
method Unsupervised machine learning using probabilistic independence to disentangle disease patterns.
result Inferred 2000 clinical disease signatures from medical records, improving cancer prediction.
For mass spectra acquired from cancer patients by MALDI or SELDI techniques, automated discrimination between cancer types or stages has often been implemented by machine learnings. These techniques typically generate "black-box" classifiers, which are difficult to interpret biologically. We develop new and efficient s…
Detecting aggressive cancer tumors using ctDNA dynamics from few blood samples.
problem Early multi-cancer detection using circulating tumor DNA (ctDNA) levels.
method Combines continuous time Markov modelling and Signature theory for efficient testing procedures.
result Correctly addresses the challenge of data scarcity in cancer monitoring.
Improved drug response prediction using ensemble learning and gene expression signatures.
problem Predicting chemotherapeutic response of cancer cells to drugs.
method Combining machine learning methods and drug-induced gene expression signatures for improved performance.
result Ensemble method improves drug activity prediction accuracy.
Deep neural network for cancer classification using autoencoders.
problem Cancer classification using molecular information.
method Using a Denoising Autoencoder (DAE) as weight initialization for a deep neural network, comparing two approaches: fixed weights and fine-tuning. Embedding strategies included encoding layers and complete autoencoder.
result Best F1 score of 98.04% for identifying thyroid cancer samples.
Machine learning clusters mutations in cancer exomes, improving diagnostic speed and cost.
problem Extracting stable mutation structures from cancer exome data for early diagnostics.
method Statistically deterministic machine learning algorithm *K-means applied to exome samples.
result Majority of cancer types exhibit stable mutation clustering, while NMF methods are unstable.
Paper identifies key CpG methylation sites for breast cancer.
problem Early detection and treatment of breast cancer.
method Used machine learning on TCGA dataset to classify cancer vs. non-cancer samples.
result Reduced model with 25 key CpG sites achieves over 94% accuracy.
Motivation : Molecular signatures for diagnosis or prognosis estimated from large-scale gene expression data often lack robustness and stability, rendering their biological interpretation challenging. Increasing the signature's interpretability and stability across perturbations of a given dataset and, if possible, acr…
Sparse Canonical Correlation Analysis (CCA) has received considerable attention in high-dimensional data analysis to study the relationship between two sets of random variables. However, there has been remarkably little theoretical statistical foundation on sparse CCA in high-dimensional settings despite active methodo…
Motivation: Biomarker discovery from high-dimensional data is a crucial problem with enormous applications in biology and medicine. It is also extremely challenging from a statistical viewpoint, but surprisingly few studies have investigated the relative strengths and weaknesses of the plethora of existing feature sele…
Deep generative model for healthcare data identifies coherent substructures and mutational clusters.
problem Analytical challenges in healthcare data, including sparsity, missingness, and small sample sizes.
method Proposes a deep generative Bayesian model with collapsed Gibbs sampling for multinomial count data.
result Identifies coherent substructures and biologically meaningful mutational clusters in cancer data.
Identifying cancer subtypes in glioblastoma by combining genomic, transcriptomic and epigenomic dataq-bio.GN
We present a nonparametric Bayesian method for disease subtype discovery in multi-dimensional cancer data. Our method can simultaneously analyse a wide range of data types, allowing for both agreement and disagreement between their underlying clustering structure. It includes feature selection and infers the most likel…
Disease Detection in Weakly Annotated Volumetric Medical Images using a Convolutional LSTM Networkcs.CV
Convolutional LSTM detects emphysema in lung cancer screening images.
problem Learning disease signatures from weakly annotated volumetric medical images.
method 3D volumetric images analyzed as a sequence of 2D images using convolutional LSTM.
result Convolutional LSTM model outperformed other methods in detecting emphysema.
Estimates cost savings from early cancer diagnosis.
problem Improving early cancer diagnosis to reduce treatment costs.
method Combining published cancer treatment cost estimates by stage with incidence rates by stage at diagnosis, and extrapolating to other cancer sites.
result Estimates U.S. national annual treatment cost-savings from early cancer diagnosis in the trillions.
Model predicts anti-cancer drug responses using gene and molecular data.
problem Expensive and time-consuming cancer drug discovery and tailoring.
method Uses variational autoencoders and multi-layer perceptrons to encode gene expression and drug data.
result High average of 0.83 and 0.845 in predicting drug responses for breast and pan-cancer cell lines, respectively.
Study uses machine learning to predict heart failure in cancer patients.
problem Early detection of cancer patients at risk for cardiotoxicity.
method Examined four machine learning algorithms on 143,199 cancer patients.
result Gradient boosting model achieved best AUC score of 0.9077.
System accurately detects lung cancer from CT images.
problem Early and accurate detection of lung cancer.
method Developed algorithms using a dataset of CT images.
result Accuracy of 72.2% on test dataset.
Deep learning models improve cancer detection and typing classification from gene expression data.
problem Challenges in establishing specificity for cancer diagnosis using gene expression data.
method Developed deep learning models using mRNA datasets for cancer detection and typing classification.
result Achieved 98% accuracy in cancer detection and 18 out of 32 cancer-typing classifications over 90% accuracy.
Using Apple Machine Learning Algorithms to Detect and Subclassify Non-Small Cell Lung Cancerq-bio.QM
Study uses Apple ML to accurately detect and classify lung cancer.
problem Accurate diagnosis and sub-classification of non-small cell lung cancer.
method Evaluation of Apple Create ML module on histopathological images.
result 100% detection and successful subclassification of non-small cell lung cancer.
Study predicts 10-year survival rates for breast cancer patients.
problem Predicting long-term survival of breast cancer patients.
method Machine learning approaches to assess survival rates.
result Improved accuracy in predicting 10-year survival.
Cancer patients admitted to ICU had improved survival over 10 years.
problem To assess changes in survival of cancer patients admitted to ICU over 10 years.
method Retrospective analysis of MIMIC-III database, adjusted for confounders using logistic regression.
result Cancer patients had significantly lower 28-day and 1-year mortality rates over 10 years.
Noise-filtering improves cancer drug sensitivity prediction.
problem Improving accuracy of cancer drug sensitivity predictions.
method Integrates numerical linear algebra and information retrieval techniques to filter out noisy cancer cell lines.
result Our approach yields the highest AUC on clinical trial data.
Prediction of Malignant & Benign Breast Cancer: A Data Mining Approach in Healthcare Applicationscs.LG
Data mining techniques predict breast cancer types with high accuracy.
problem Early detection of breast cancer to reduce mortality rates.
method Twelve classification algorithms applied to the Breast Cancer Wisconsin dataset.
result High accuracy in predicting malignant and benign breast cancer.
The development of molecular signatures for the prediction of time-to-event outcomes is a methodologically challenging task in bioinformatics and biostatistics. Although there are numerous approaches for the derivation of marker combinations and their evaluation, the underlying methodology often suffers from the proble…
Study examines perceptions and attitudes about breast cancer on Twitter.
problem Understanding public perceptions and attitudes towards breast cancer on social media.
method Identified and collected tweets, used topic modeling and sentiment analysis.
result Identified themes and quantified users' perceptions and emotions about breast cancer.
Deep learning predicts breast cancer with high accuracy from patient data.
problem Early detection of breast cancer from patient data.
method Feature selection and k-fold Monte Carlo cross-validation using deep learning.
result Deep learning model effectively distinguishes between cancer and healthy patients.
Machine learning accurately diagnoses cancer from whole genome sequencing data.
problem Accurate cancer diagnosis at all stages.
method Novel MLAC (Machine Learning Against Cancer) method using next-gen RNA sequencing.
result Perfect precision, sensitivity, and specificity achieved for most tumor types.
Neural networks improve cancer risk prediction from family history data.
problem Improving cancer risk prediction from family history data using machine learning.
method Developed and trained neural network models on large pedigrees to predict hereditary cancers.
result Neural networks can achieve nearly optimal prediction performance and outperform traditional models in misreported data.
Machine learning detects metastatic breast cancer cases from linked EMR and cancer registry data.
problem Lack of metastatic recurrence data in cancer registries and EMRs.
method Semi-supervised machine learning on linked EMR and CCR data.
result Model achieved high accuracy in detecting metastatic breast cancer cases.
L-Perceptron improves breast cancer diagnosis and survival prediction.
problem Improving early prognosis and survival prediction rates for breast cancer.
method Proposes a novel type of perceptron (L-Perceptron) for better accuracy and sensitivity.
result Achieves 97.42% and 98.73% accuracy and sensitivity in Wisconsin Breast Cancer dataset.
System automates identification of cancer drug repurposing from PubMed.
problem Manual extraction of cancer drug repurposing evidence from scientific publications is infeasible.
method NLP pipeline including querying, filtering, entity extraction, classification, and study type classification.
result Automated system extracts cancer drug repurposing evidence from PubMed abstracts.
PathologyGAN learns deep representations of cancer tissue images.
problem Limited high-quality labels for cancer tissue images.
method Developed a GAN framework for unsupervised learning of cancer tissue phenotypes.
result Generated high-quality images with interpretable latent space.
Study identifies biomarkers for lung cancer in female non-smokers.
problem Identifying prognostic biomarkers for stage III NSCLC in non-smoking females.
method Gene expression profiling and XGBoost machine learning algorithm.
result Top biomarkers validated in literature, with AUC score of 0.835.
A Deep Autoencoder System for Differentiation of Cancer Types Based on DNA Methylation Stateq-bio.QM
Deep autoencoder predicts cancer types from DNA methylation patterns.
problem Differentiating cancer types based on DNA methylation states.
method Deep learning system with CpG island state classification and statistical methods.
result Overall Sensitivity of 88.24%, Specificity of 83.33%, Accuracy of 84.75%.
Deep CNN model improves breast cancer screening exam classification.
problem Improving accuracy in breast cancer screening exam classification.
method Localization-based deep CNN trained on 200,000 exams.
result AUC of 0.919 in predicting malignancy, reducing error rate by 23%.
Modeling correlated mutations in cancer for personalized treatment.
problem Identifying mutations for personalized cancer therapy in heterogeneous profiles.
method Proposed correlated zero-inflated negative binomial process with mixed beta-Bernoulli and variational inference.
result Identified biologically relevant correlations between somatic mutations.
Network Elastic Net identifies smoking-specific gene expression for lung cancer prognosis.
problem Identifying smoking-specific gene expression biomarkers in lung cancer prognosis.
method Introduces Network Elastic Net, a method that clusters and regresses on graphs based on smoking behavior.
result Shows efficacy of clusters in identifying cancer stages using gene expression and smoking behavior.
The study improves colorectal cancer survivability prediction by considering ethnicity.
problem Improving colorectal cancer survivability prediction using machine learning.
method Machine learning techniques applied to SEER cancer incidence database, comparing different ethnicities.
result Models perform better on single-ethnicity populations and provide different feature importance rankings.
Scalable Reinforcement-Learning-Based Neural Architecture Search for Cancer Deep Learning Researchcs.LG
Automates deep learning model development for cancer data.
problem Manual design of high-performing deep learning models for cancer data is time-consuming and requires expertise.
method Reinforcement-learning-based neural architecture search with custom building blocks.
result Automated discovery of deep neural network architectures with similar or higher accuracy.
Deep learning improves prostate cancer diagnosis using MRI.
problem Improving accuracy in prostate cancer diagnosis.
method Developed XmasNet, a deep learning architecture based on convolutional neural networks, trained on 3D multiparametric MRI data.
result XmasNet outperformed traditional machine learning models and achieved the second highest AUC (0.84) in the PROSTATEx challenge.
BIDIFAC+ factorizes linked matrices for cancer studies.
problem Integrating multiple omics platforms across various cancer types.
method Flexible approach to simultaneous factorization and decomposition of linked matrices using BIDIFAC+.
result Identifies shared and specific modes of variability across multiple omics platforms and cancer types.
Paper proposes scalable method for analyzing multi-omic data.
problem Integrating high-dimensional multi-omic data for cancer subtyping.
method Mixed graphical model approach using Birth-Death MCMC algorithm.
result Our method outperforms LASSO and standard BDMCMC in computational efficiency and model selection accuracy.
Model learns cancer tissue images onto a low-dimensional space revealing tissue characteristics.
problem Improving cancer diagnosis through high-fidelity digital pathology.
method Deep generative model using PathologyGAN to map real images onto a latent space.
result Latent space encodes morphological characteristics and reveals distinct tissue clusters.
Machine learning can predict cancer with 100% accuracy on a dataset.
problem Accuracy of cancer predictions using machine learning.
method Extensive experiments on the Wisconsin Diagnostic Breast Cancer dataset.
result Machine learning algorithms can be easily misled to achieve 100% accuracy.
Model predicts drug response in tumors using genomic profiles.
problem Challenges in translating genomic insights to tumor-specific drug response predictions.
method Deep neural network (DNN) model trained on mutation and expression profiles of cancer cell lines.
result Achieved mean squared error of 1.96 for predicting IC50 values of 265 drugs.
DeePathology: Deep Multi-Task Learning for Inferring Molecular Pathology from Cancer Transcriptomestat.ML
Deep neural networks infer multiple cancer properties from transcriptome data.
problem Limited use of biomarkers in molecular cancer pathology due to computational challenges.
method Multi-task and transfer learning architecture encoding whole transcriptome into a latent vector.
result Significantly better at predicting tissue-of-origin, disease state, and cancer type.